Search for: "Merck & Co, Inc. " Results 401 - 420 of 664
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Feb 2020, 6:33 am
Merck & Co., the Third Circuit held that plaintiffs who opt out of a securities class action are not precluded under the Securities Litigation Uniform Standards Act of 1998 (SLUSA) from bringing state law fraud claims in follow-on individual actions, even if federal claims are time-barred. [read post]
29 Mar 2010, 9:26 am
In re Keller, 642 F.2d 413, 208 USPQ 871 (CCPA 1981); In re Merck & Co., Inc., 800 F.2d 1091, 231 USPQ 375 (Fed. [read post]
8 Feb 2017, 3:09 am by Dennis Crouch
Extraterritoriality – Trade Secrecy: Sino Legend (Zhangjiagang) Chemical Co. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Anticipation/Obviousness: Merck & Cie, et al. v. [read post]
11 Jul 2007, 7:01 am
Johnson & Johnson & Merck Consumer Pharmaceuticals, Co., 129 F. [read post]
21 Mar 2007, 6:25 pm
Trustees for the Retirement Plan for the Hourly Employees of Merck & Co. [read post]
14 Dec 2006, 12:09 am
. Jury Finds for Merck at Federal Vioxx Trial in New Orleans The Associated Press In the fourth victory for drug maker Merck & Co. in five federal trials, a New Orleans jury has rejected a Tennessee man's claim that the withdrawn painkiller Vioxx was a cause of his heart attack. [read post]
15 Feb 2007, 12:00 am
-based SEC lawyers want to file civil charges at the same time -- and they're not ready yet. Merck Agrees to Pay IRS $2.3 Billion to Settle Tax Disputes The Associated Press Merck & Co., mired in multibillion-dollar litigation over Vioxx, has eliminated another legal headache, resolving several tax disputes with the IRS by agreeing to a $2.3 billion settlement. [read post]
29 Jun 2011, 3:34 am by Marie Louise
Merck & Co Inc v Deutsches Patent- und Markenamt (The SPC blog) Europe: SPC: waiting for the Court of Justice of the European Union (Kluwer Patent Blog) India: Roger Bates, pharma patents and contempt of court? [read post]
12 May 2015, 3:26 pm by James Galvin
Inc. 902641802 UBS Yield Optimization Securities with Contingent Protection linked to McDonald’s Corp. 902641851 UBS Yield Optimization Securities with Contingent Protection linked to Schlumberger, Ltd. 902641869 UBS Yield Optimization Securities with Contingent Protection linked to Oracle Corp. 902641877 UBS Yield Optimization Securities with Contingent Protection linked to Dell Inc. 902641885 UBS Yield Optimization Securities with Contingent Protection linked to AT&T… [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
  This long-running litigation involves a challenge by direct purchasers of K-DUR (potassium chloride) Extended-release Tablets who allege that Merck & Co., Inc. [read post]
23 Sep 2007, 2:28 pm
Merck & Co., Nos. 2005-59499 and 2005-58543, 2007 WL 1181991 (Tex. [read post]
8 Jul 2010, 9:00 am by Chelsey Russell
Kidder has been a director for Morgan Stanley since 1993 and also sits on the Board of Merck & Co., Inc. and Chrysler Group LLC as a Non-Executive Chairman. [read post]
23 Apr 2010, 8:20 am by Press Releases
” Expected to attend are IP leaders from BP America Inc., Merck & Co., Inc., Bose, Brigham Young University, Cornell University, Stanford University, Duke University, Georgetown University, GlaxoSmithKline, Honeywell, Harvard University, Johnson & Johnson, Kauffman Foundation, Lockheed Martin, Massachusetts Institute of Technology (MIT), Mayo Clinic, Ortho-McNeil Pharmaceuticals Inc., Rutgers, Syngenta Biotechnology, Scripps Research… [read post]
24 Feb 2011, 9:02 am by Lawrence B. Ebert
UMass licensed its interest in the Tuschl I patent applications for therapeutic use to Alnylam's competitor, Sirna Therapeutics, which was later acquired by Merck & Co. [read post]